Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Related Concept Videos

Cystic Fibrosis: Pathogenesis01:23

Cystic Fibrosis: Pathogenesis

455
Cystic fibrosis (CF), an autosomal recessive disorder, significantly affects the function of exocrine glands. This genetically inherited disease is characterized by the production of thick and sticky mucus, which can severely affect various organs and systems in the body.
CF is primarily caused by a genetic mutation in a chromosome 7 gene coding for the cystic fibrosis transmembrane conductance regulator (CFTR) protein. The most common gene mutation leading to CF is the ΔF508 mutation,...
455
Urinary Tract Infection II: Pathophysiology01:25

Urinary Tract Infection II: Pathophysiology

209
The pathophysiology of urinary tract infections (UTIs) encompasses several progressive stages, beginning with bacterial colonization and culminating in potential systemic complications if untreated. UTIs are primarily initiated by bacteria, such as Escherichia coli, which often originate from the gastrointestinal tract and migrate to the urinary system through the periurethral area. This migration can occur via several routes, including improper hygiene practices, sexual activity, or...
209
Pulmonary Hypertension: Classification and Pathogenesis01:30

Pulmonary Hypertension: Classification and Pathogenesis

347
Pulmonary hypertension (PH) is a severe health condition in which the mean pulmonary arterial pressure increases to 25 mmHg or more, even when the body is at rest. This high pressure in the blood vessels that transport blood from the heart to the lungs can cause various symptoms, including shortness of breath, can lead to right heart failure, and significantly affect the overall quality of life.
There are various classifications for PH, each relating to different underlying causes and also...
347
Sex-linked Disorders01:43

Sex-linked Disorders

104.1K
Like autosomes, sex chromosomes contain a variety of genes necessary for normal body function. When a mutation in one of these genes results in biological deficits, the disorder is considered sex-linked.
104.1K
Gene Therapy00:59

Gene Therapy

26.2K
Gene therapy is a technique where a gene is inserted into a person’s cells to prevent or treat a serious disease. The added gene may be a healthy version of the gene that is mutated in the patient, or it could be a different gene that inactivates or compensates for the patient’s disease-causing gene. For example, in patients with severe combined immunodeficiency (SCID) due to a mutation in the gene for the enzyme adenosine deaminase, a functioning version of the gene can be...
26.2K
Nephrotic Syndrome II : Assessment and Medical Management01:26

Nephrotic Syndrome II : Assessment and Medical Management

45
IntroductionNephrotic syndrome is a kidney disorder marked by excessive protein loss in the urine, leading to various systemic complications. This condition often results from damage to the glomeruli—the kidney's filtering units—causing proteinuria, low blood protein levels, and fluid retention. Understanding the assessment, diagnosis, and management of nephrotic syndrome is essential for effective treatment and prevention of further kidney damage.AssessmentPatient History: Document...
45

You might also read

Related Articles

Articles linked to this work by shared authors, journal, and citation graph.

Sort by
Same author

Ultra-weak photon emission during ischemia-reperfusion: Characterizing response dynamics and reproducibility.

Journal of photochemistry and photobiology. B, Biology·2026
Same author

Impact of HbA1c Reduction on Major Kidney Outcomes in Type 2 Diabetes With Poor Glycemic Control and Advanced CKD.

International journal of endocrinology·2025
Same author

Long-Read Whole-Genome Sequencing as a Tool for Variant Detection in Inherited Retinal Dystrophies.

International journal of molecular sciences·2025
Same author

Outcomes of a Pilot Newborn Screening Program for Spinal Muscular Atrophy in the Valencian Community.

International journal of neonatal screening·2025
Same author

De novo and inherited dominant variants in U4 and U6 snRNAs cause retinitis pigmentosa.

medRxiv : the preprint server for health sciences·2025
Same author

Variants in the AGBL5 gene are responsible for autosomal recessive Retinitis pigmentosa with hearing loss.

European journal of human genetics : EJHG·2024

Related Experiment Video

Updated: Oct 26, 2025

A Scalable, Cell-Based Method for the Functional Assessment of Ube3a Variants
06:35

A Scalable, Cell-Based Method for the Functional Assessment of Ube3a Variants

Published on: October 10, 2022

2.1K

Genetics, pathogenesis and therapeutic developments for Usher syndrome type 2.

M Stemerdink1, B García-Bohórquez2,3, R Schellens1

  • 1Department of Otorhinolaryngology, Donders Institute for Brain, Cognition and Behaviour, Radboud University Medical Center, 6525 GA, Nijmegen, The Netherlands.

Human Genetics
|July 31, 2021
PubMed
Summary
This summary is machine-generated.

Usher syndrome type 2 (USH2) causes hearing and vision loss. Research reviews USH2 genetics, models, and emerging therapies, with one treatment in clinical trials.

More Related Videos

In Vivo Functional Study of Disease-associated Rare Human Variants Using Drosophila
06:41

In Vivo Functional Study of Disease-associated Rare Human Variants Using Drosophila

Published on: August 20, 2019

13.9K
Measuring Enzymatic Activity of Neurodevelopmental Disorder-Associated Deubiquitylating Enzymes via an In Vitro Ubiquitin Chain Cleavage Assay
07:05

Measuring Enzymatic Activity of Neurodevelopmental Disorder-Associated Deubiquitylating Enzymes via an In Vitro Ubiquitin Chain Cleavage Assay

Published on: September 27, 2024

661

Related Experiment Videos

Last Updated: Oct 26, 2025

A Scalable, Cell-Based Method for the Functional Assessment of Ube3a Variants
06:35

A Scalable, Cell-Based Method for the Functional Assessment of Ube3a Variants

Published on: October 10, 2022

2.1K
In Vivo Functional Study of Disease-associated Rare Human Variants Using Drosophila
06:41

In Vivo Functional Study of Disease-associated Rare Human Variants Using Drosophila

Published on: August 20, 2019

13.9K
Measuring Enzymatic Activity of Neurodevelopmental Disorder-Associated Deubiquitylating Enzymes via an In Vitro Ubiquitin Chain Cleavage Assay
07:05

Measuring Enzymatic Activity of Neurodevelopmental Disorder-Associated Deubiquitylating Enzymes via an In Vitro Ubiquitin Chain Cleavage Assay

Published on: September 27, 2024

661

Area of Science:

  • Genetics and ophthalmology
  • Auditory and vestibular science
  • Rare disease research

Background:

  • Usher syndrome (USH) is a rare, autosomal recessive disorder causing sensorineural hearing loss and retinitis pigmentosa (RP).
  • USH type 2 (USH2) is the most common form, affecting photoreceptor and inner ear hair cells.
  • Additional symptoms may include olfactory dysfunction and altered vestibular function.

Purpose of the Study:

  • To review the genetic and clinical aspects of Usher syndrome type 2 (USH2).
  • To assess available disease models for USH2.
  • To discuss current therapeutic developments for USH2.

Main Methods:

  • Literature review of genetic and clinical studies on USH2.
  • Analysis of patient-derived cellular and animal models (mouse, zebrafish, drosophila).
  • Evaluation of ongoing therapeutic strategies, including gene and cell-based therapies.

Main Results:

  • Mutations in USH2A, ADGRV1, and WHRN genes cause USH2, with USH2A mutations accounting for 50% of cases.
  • USH2 proteins form a complex crucial for photoreceptor and inner ear hair cell function.
  • Existing models partially replicate USH2 phenotypes, aiding research.

Conclusions:

  • USH2 is a complex genetic disorder affecting multiple sensory systems.
  • Therapeutic approaches, particularly for visual function, are advancing, with one in clinical trials.
  • These developments offer hope for future USH2 treatments.